Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
6.10
-2.43 (-28.49%)
Jun 1, 2026, 1:53 PM EDT - Market open
Co-Diagnostics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 8.23 | 11.88 | 2.94 | 14.92 | 22.97 | 88.61 |
Short-Term Investments | - | - | 26.81 | 43.63 | 58.29 | 1.26 |
Cash & Short-Term Investments | 8.23 | 11.88 | 29.75 | 58.55 | 81.26 | 89.86 |
Cash Growth | -61.68% | -60.05% | -49.19% | -27.95% | -9.57% | 89.94% |
Accounts Receivable | 0.08 | 0.19 | 0.13 | 0.3 | 3.45 | 20.84 |
Other Receivables | 0 | 0.04 | - | 0.03 | 1.95 | 0.08 |
Total Trade Receivables | 0.08 | 0.23 | 0.13 | 0.33 | 5.4 | 20.91 |
Inventory | 0.85 | 0.99 | 1.07 | 1.66 | 5.31 | 2 |
Other Current Assets | 0.62 | 0.58 | 1.34 | 1.6 | 0.76 | 2.34 |
Total Current Assets | 9.78 | 13.69 | 32.29 | 62.14 | 92.73 | 115.12 |
Net Property, Plant & Equipment | 4.16 | 3.48 | 4.88 | 6 | 2.91 | 1.93 |
Other Intangible Assets | 7.22 | 7.22 | 26.1 | 26.4 | 26.77 | 27.2 |
Goodwill | - | - | - | - | - | 14.71 |
Long-Term Investments | 0.34 | 0.35 | 0.29 | 0.77 | 0.67 | 1 |
Other Long-Term Assets | - | - | - | - | - | 0.08 |
Total Assets | 21.5 | 24.74 | 63.56 | 95.32 | 123.09 | 160.03 |
Accounts Payable | 2.02 | 1.88 | 3.29 | 1.48 | 0.95 | 0.61 |
Accrued Expenses | 1.36 | 0.87 | 2.56 | 2.17 | 0.93 | 3.86 |
Current Portion of Leases | 0.86 | 0.66 | 0.92 | 0.84 | 0.3 | - |
Unearned Revenue | 0 | 0.01 | 0.04 | 0.36 | - | 0.15 |
Other Current Liabilities | 0.04 | 0.12 | 0.5 | 0.89 | 1.69 | 7.98 |
Total Current Liabilities | 4.28 | 3.54 | 7.32 | 5.75 | 3.87 | 12.6 |
Long-Term Leases | 1.17 | 0.57 | 1.24 | 2.15 | 0.05 | - |
Other Long-Term Liabilities | - | - | 1.14 | 1.41 | 4.64 | 12.96 |
Total Long-Term Liabilities | 1.17 | 0.57 | 2.37 | 3.56 | 4.69 | 12.96 |
Total Liabilities | 5.46 | 4.11 | 9.69 | 9.31 | 8.57 | 25.56 |
Common Stock | 0.07 | 0.07 | 0.04 | 0.04 | 0.03 | 0.03 |
Treasury Stock | -15.58 | -15.58 | -15.58 | -15.58 | -14.21 | - |
Additional Paid-in Capital | 121.06 | 116.51 | 102.47 | 96.81 | 88.47 | 80.27 |
Accumulated Other Comprehensive Income | - | - | 0.42 | 0.15 | 0.29 | - |
Retained Earnings | -89.51 | -80.37 | -33.48 | 4.6 | 39.93 | 54.17 |
Shareholders' Equity | 16.04 | 20.63 | 53.88 | 86.01 | 114.52 | 134.48 |
Total Liabilities & Equity | 21.5 | 24.74 | 63.56 | 95.32 | 123.09 | 160.03 |
Total Debt | 2.03 | 1.24 | 2.15 | 2.99 | 0.35 | 0 |
Net Cash (Debt) | 6.2 | 10.65 | 27.6 | 55.56 | 80.92 | 89.86 |
Net Cash Growth | -41.77% | -61.41% | -50.33% | -31.34% | -9.96% | 89.94% |
Net Cash Per Share | 3.81 | 8.01 | 27.29 | 56.80 | 77.11 | 90.15 |
Book Value | 16.04 | 20.63 | 53.88 | 86.01 | 114.52 | 134.48 |
Book Value Per Share | 9.87 | 15.51 | 53.28 | 87.93 | 109.14 | 134.91 |
Tangible Book Value | 8.82 | 13.41 | 27.77 | 59.61 | 87.75 | 92.57 |
Tangible Book Value Per Share | 5.43 | 10.08 | 27.47 | 60.94 | 83.63 | 92.87 |